Related Experiment Video

Updated: Jul 9, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines

Jens E Ruhe1, Sylvia Streit, Stefan Hart

  • 1Institute of Medical Biology, Singapore, Singapore. ruhe@u3pharma.com

Cancer Research
|December 7, 2007
PubMed

Insights

This study analyzed protein tyrosine kinases (PTKs) in 254 cancer cell lines, identifying genetic variations like polymorphisms and somatic mutations. These findings offer insights into cancer signaling and drug sensitivity for improved research and therapeutics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Protein tyrosine kinases (PTKs) are crucial regulators of cancer cell properties.
  • Signaling pathways involving PTKs are extensively studied in immortalized tumor cells.

Purpose of the Study:

  • To characterize variations in the primary structure of all expressed PTKs across 254 established cancer cell lines.
  • To create a database of PTK alterations for cancer research.
  • To evaluate the functional relevance of identified genetic alterations.

Main Methods:

  • cDNA-based sequence analysis of the entire tyrosine kinase transcriptome.
  • Analysis of 254 established tumor cell lines.
  • Identification and cataloging of polymorphisms and somatic mutations.

Main Results:

  • Generated the "Tykiva" database detailing PTK transcript alterations, including 155 polymorphisms and 234 somatic mutations.
  • Identified functionally relevant genetic alterations, such as Y367 in fibroblast growth factor receptor 4 and Q26X in CSK.
  • Detected known drug-sensitivity variants (e.g., EGFR G719S) in novel tumor types.

Conclusions:

  • The Tykiva database provides comprehensive system information for cancer cell line research.
  • Identified PTK alterations may influence cell line-specific signaling and tumor progression.
  • Findings support further investigation into clinical applications of cancer therapeutics based on PTK variants.

More Related Videos

Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...